Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373035 · ClinicalTrials.gov registry record
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 60
- Enrollment target
NCT00373035 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants.
The verdict
NCT00373035 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of blood and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients undergoing transrectal ultrasound prostate biopsy.
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE biopsy
- OTHER mass spectrometry
- GENETIC proteomic profiling
- OTHER immunological diagnostic method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373035
The ClinicalTrials.gov registry entry for NCT00373035 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00373035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373035 about?
NCT00373035 is a clinical study titled "Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy". RATIONALE: Collecting and storing samples of blood and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients undergoing...
What is the current status of trial NCT00373035?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-02.
What interventions are being tested in trial NCT00373035?
The interventions under investigation include: laboratory biomarker analysis (OTHER), biopsy (PROCEDURE), mass spectrometry (OTHER), proteomic profiling (GENETIC), immunological diagnostic method (OTHER).
Who is sponsoring clinical trial NCT00373035?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.